Considering the impact NLRX1 demonstrated on several cancer-associated phenotypes in our Pan02 cells, we next collected RNA from Pan02OE, Pan02OE-CTL, Pan02KD, and Pan02KD-CTL cells for transcriptomics analysis (ClariomS). This evidence concerns the gene NLRX1 and cancer.